MacroGenics (MGNX)
NASDAQ:MGNX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 149.50M | $ 148.34M | $ 57.19M | $ 150.02M | $ 75.64M |
| Gross Profit | $ 106.32M | $ 136.04M | $ 48.97M | $ 142.63M | $ 72.99M |
| Operating Income | $ -72.84M | $ -110.58M | $ -168.24M | $ -121.42M | $ -202.79M |
| EBITDA | $ -65.67M | $ -57.37M | $ 2.02M | $ -107.89M | $ -190.86M |
| Net Income | $ -74.62M | $ -66.97M | $ -9.06M | $ -119.76M | $ -202.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 189.91M | $ 201.67M | $ 229.81M | $ 154.35M | $ 243.62M |
| Total Assets | $ 256.85M | $ 261.65M | $ 298.42M | $ 289.51M | $ 335.25M |
| Total Debt | $ 106.76M | $ 37.46M | $ 33.97M | $ 34.83M | $ 25.47M |
| Net Debt | $ 49.55M | $ -145.38M | $ -66.98M | $ -74.05M | $ -98.00M |
| Total Liabilities | $ 201.25M | $ 145.60M | $ 145.81M | $ 147.50M | $ 95.63M |
| Stockholders' Equity | $ 55.59M | $ 116.06M | $ 152.61M | $ 142.01M | $ 239.62M |
| Cash Flow | |||||
| Free Cash Flow | $ -82.95M | $ -72.08M | $ -79.97M | $ -90.58M | $ -150.03M |
| Operating Cash Flow | $ -81.04M | $ -68.37M | $ -78.20M | $ -86.96M | $ -143.83M |
| Investing Cash Flow | $ -114.10M | $ 149.30M | $ -80.08M | $ 70.72M | $ -36.61M |
| Financing Cash Flow | $ 69.51M | $ 960.00K | $ 150.36M | $ 1.66M | $ 122.78M |